VENN STRATEGIES, LLC

Lobbying for AVANIR PHARMACEUTICALS, INC. · Biopharmaceutical research and manufacturing.

Filing 1st Quarter - Amendment

1st Quarter (Jan 1 - Mar 31) 2022 · California · House · $50,000.00 income · posted Jul 2, 2026

Lobbying activity 1

Health Issues

Access to and innovation in biopharmaceuticals, including through policies related to payment, pricing, and clinical trials.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.